Award
NIH Reporter #1R43AG102309-01
RadBot: Next-Generation Drug Discovery for Environmental Stress Resistance Using Longevity Biology
Recipient
Ora Biomedical, Inc.
Award Amount
$299,783.00
Ceiling
$299,783.00
Awarded
September 17, 2026
Identifier
1R43AG102309-01
Ora Biomedical, Inc. received NIH funding through the National Institute on Aging for a project developing and validating longevity-biology-based interventions to protect against UV damage and related aging effects.
Description
Funding to develop small-molecule formulations that activate cellular longevity pathways to protect against ultraviolet-induced damage, using high-throughput screening and validation in human cell and animal models.